Transcript an up date - Formazione Ospedale Pediatrico Bambino Gesù

GENERAL INFORMATION
MEETING VENUE:
AN UP DATE: 8 NOVEMBER 2014
Aula Newman ‐ Pontificia Universitas Urbaniana
Via Urbano VIII, 16 ‐ Rome
RETINOBLASTOMA
INTERNATIONAL FORUM
REGISTRATION
Participants are required to sign up on‐line at:
http://www.formazione.ospedalebambinogesu.it/
Only the first 100 registrations will be accepted.
O i
On‐site
registrations
i
i
will
ill be
b accepted
d if the
h maximum
i
number
b
off
participants has not yet been reached.
Registration is free. 8 November
8 November 2014, 2014, Rome
Rome
Under the patronage of
Under the patronage of::
English simultaneous translation provided.
CONTINUING MEDICAL EDUCATION (CME)
According to the procedure established by the Italian Health Ministry, the
training will attribute learning credits to the following professions:
Medical Doctors (Paediatricians, Paediatric oncologists, Ophthalmologists).
The credits will be attributed to the participant provived that he/she attends
the whole training programme. His/her attendance will be verified through
manual registration (signing in/out), the filing in of the event satisfaction
survey and the checking of the learning assessment form.
ORGANIZING SECRETARIAT:
Servizio Eventi Formativi ECM
Bambino Gesù IRCCS Children's Hospital P.zza S. Onofrio, 4 ‐ 00165 Rome
Tel: 06‐6859.2411‐4864‐2290‐3768‐3770 Fax: 06/6859 2443
Fax: 06/6859.2443
E‐mail: [email protected]
www.ospedalebambinogesu.it
SIOP
AIMO (richiesto)
SOI (da richiedere)
Aula Newman
Pontificia Universitas
Pontificia Universitas Urbaniana
Via Urbano VIII, 16 Via Urbano VIII, 16 ‐‐ Rome
Course Presentation
Speakers Retinobastoma is the most common ocular tumor of childhood.
Recently diagnosis and treatment procedures have greatly developed.
At Bambino Gesù Hospital world's experts in Retinoblastoma will hold
an international meeting to discuss scientific knowledges and clinic
aspects.
The meeting will promote international cooperation following the first
meeting
ti off the
th European
E
R ti bl t
Retinoblastoma
P j t held
Project
h ld in
i Paris
P i
Guillermo L. CHANTADA
HONORARY COMMITTEE
Livia LUMBROSO
Giuseppe PROFITI, President Bambino Gesù IRCCS Children’s Hospital
President, Bambino Gesù IRCCS Children’s Hospital
Bruno DALLAPICCOLA, Scientific Director , Bambino Gesù IRCCS Children’s Hospital
Massimiliano RAPONI,
Chief Medical Director Bambino Gesù IRCCS Children’s Hospital
Chief Medical Director, Bambino Gesù IRCCS Children
s Hospital
Luca BUZZONETTI
Ophthalmology Department
Bambino Gesù IRCCS Children's Hospital – Rome
COURSE DIRECTOR
JP Garrahan Hospital, Buenos Aires, Argentina
p ,
, g
Sant Joan de Déu Hospital, Barcelona Children’s Hospital, Barcelona, Spain
Laurance DESJARDIN
CURIE Institute, Paris, France
Francois DOZ
CURIE Institute and University Paris Descartes, Paris, CURIE Institute, Paris, France
Edoardo MIDENA
University Hospital of Padua, Italy
Francis MUNIER
Jules Gonin Eye Hospital, Geneva, Switzerland
Gian Luigi NATALI
Interventional Radiology Department
Bambino Gesù IRCCS Children's Hospital – Rome, Italy
Maya Beck POPOVICH
L
Lausanne University
U i
it Hospital, Geneva, Switzerland
H
it l G
S it l d
Raffaele COZZA
Department of Pediatric Hematology and Oncology
Bambino Gesù IRCCS Children's Hospital ‐ Rome
Theodora HADJISTILIANOU
Antonino ROMANZO
Ophthalmology Department
Bambino Gesù IRCCS Children's Hospital – Rome
Paolo NUCCI
University of Milan; San Giuseppe Hospital Italian Society of Paediatric Ophthalmology
SCIENTIFIC SECRETARIAT
Elena PIOZZI
Maria Antonietta DE IORIS
Department of Pediatric Hematology and Oncology
Bambino Gesù IRCCS Children's Hospital – Rome
Paola VALENTE
l
Ophthalmology Department Bambino Gesù IRCCS Children's Hospital – Rome
Le Scotte University Hospital, Siena, Italy
Moderator
Niguarda Hospital, Milan
Maria Antonietta BLASI
A. Gemelli University Hospital, Rome
Gianni BISOGNO
Gi
i BISOGNO
University Hospital of Padua
Scientific program
08.00 Registration of participants
08.15 Welcome address and opening remarks
G. Profiti, B. Dallapiccola, M. Raponi
fi i
ll i l
i
10.30 Seeding in Retinoblastoma: recognition, management and the regression patterns
F. Munier
10.50 Discussion
Chairman: M.A. Blasi, P. Nucci, E. Piozzi, G. Bisogno
08.30 First line
08
30 First line conservative strategies for
Retinoblastoma: the Institute Curie experience
L. Lumbroso
5
08.50 Discussion
09.00 Intraocular Retinoblastoma: what is the best chemio‐therapy today
G. L. Chantada
11.00 Treatment of recurrent or progressive intraocular retinoblastoma
M.B. Popovic
11.20 Discussion
11.3o Intravitreal chemotherapy: new drugs in the future
E. Midena, F. Munier
11.50 Discussion
09.20 Discussion
12.00 Retinoblastoma in Europa : a new project
G. Chantada, F. Doz
09.30 Pre‐enucleation chemotherapy
F Doz
F. Doz
12.20 Discussion
09.50 When and how modify the therapeutical approach
and/or to stop the conservative treatment. Does the enucleation risk to become a therapeutic
late solution ?
L. Desjardin
10.10 Discussion
12.30 Pearls and pitfalls of intraarterial chemotherapy for retinoblastoma Intrarterial
G.L. Natali, T. Hadjistilianou
13.00 Discussion
13.30 Post course test
14.00 Conclusions and Lunch
Ringraziamenti SPONSOR